Wimbley D - Search Results

Year	Number of Results
2008	3
2009	3
2014	1
2015	1
2024	0

1

Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection.

Mitchell CD, Chernoff MC, Seage GR 3rd, Purswani MU, Spiegel HM, Zilleruelo G, Abitbol C, Heckman B, Ponce CB, Oleske JM; IMPAACT 219/219C Study Team. Mitchell CD, et al. Pediatr Nephrol. 2015 Jan;30(1):153-65. doi: 10.1007/s00467-014-2909-1. Epub 2014 Aug 24. Pediatr Nephrol. 2015. PMID: 25149850 Free PMC article.

2

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, Borum P, Meyer WA 3rd, Hardin DS, Mulligan K; Pediatric AIDS Clinical Trials Group P1045 team. Aldrovandi GM, et al. AIDS. 2009 Mar 27;23(6):661-72. doi: 10.1097/QAD.0b013e3283269dfb. AIDS. 2009. PMID: 19279441 Free PMC article.

3

Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.

Van Dyke RB, Wang L, Williams PL; Pediatric AIDS Clinical Trials Group 219C Team. Van Dyke RB, et al. J Infect Dis. 2008 Dec 1;198(11):1599-608. doi: 10.1086/593022. J Infect Dis. 2008. PMID: 19000014 Free PMC article.

4

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team. Nachman SA, et al. Arch Pediatr Adolesc Med. 2009 Feb;163(2):164-71. doi: 10.1001/archpedi.163.2.164. Arch Pediatr Adolesc Med. 2009. PMID: 19188649 Free PMC article.

5

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team. Patel K, et al. AIDS. 2009 Sep 10;23(14):1893-901. doi: 10.1097/QAD.0b013e32832dc041. AIDS. 2009. PMID: 19644348 Free PMC article. Clinical Trial.

6

Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team. Patel K, et al. Clin Infect Dis. 2008 Jun 1;46(11):1751-60. doi: 10.1086/587900. Clin Infect Dis. 2008. PMID: 18426371 Free PMC article.

7

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team. Tassiopoulos K, et al. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16. J Acquir Immune Defic Syndr. 2008. PMID: 18209684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year